Dore, G., Conway, B., Luo, Y., Janczewska, E., Knysz, B., Liu, Y., Streinu-Cercel, A., Caruntu, F., Curescu, M., Skoien, R., Ghesquiere, W., Mazur, W., Soza, A., Fuster, F., Greenbloom, S., Motoc, A., Arama, V., Shaw, D.,
Tornai, I., Sasadeusz, J., Dalgard, O., Sullivan, D., Liu, X., Kapoor, M., Campbell, A., Podsadecki, T.:
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: the MALACHITE-I/II trials.
J. Hepatol. 64 (1), 19-28, 2016.